These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 31997882)

  • 1. Safety And Efficacy Of The Unique Opioid Buprenorphine For The Treatment Of Chronic Pain.
    Pergolizzi JV; Raffa RB
    J Pain Res; 2019; 12():3299-3317. PubMed ID: 31997882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Narrative Pharmacological Review of Buprenorphine: A Unique Opioid for the Treatment of Chronic Pain.
    Gudin J; Fudin J
    Pain Ther; 2020 Jun; 9(1):41-54. PubMed ID: 31994020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Buprenorphine buccal film for chronic pain management.
    Hale M; Gimbel J; Rauck R
    Pain Manag; 2020 Jul; 10(4):213-223. PubMed ID: 32394800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the Tolerability of Switching Patients on Chronic Full μ-Opioid Agonist Therapy to Buccal Buprenorphine.
    Webster L; Gruener D; Kirby T; Xiang Q; Tzanis E; Finn A
    Pain Med; 2016 May; 17(5):899-907. PubMed ID: 26917621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Buprenorphine 5, 10 and 20 μg/h transdermal patch: a review of its use in the management of chronic non-malignant pain.
    Plosker GL
    Drugs; 2011 Dec; 71(18):2491-509. PubMed ID: 22141389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Benefit-Risk Analysis of Buprenorphine for Pain Management.
    Hale M; Garofoli M; Raffa RB
    J Pain Res; 2021; 14():1359-1369. PubMed ID: 34079354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of Buprenorphine Rotation in Patients Receiving Long-term Opioids for Chronic Pain: A Systematic Review.
    Powell VD; Rosenberg JM; Yaganti A; Garpestad C; Lagisetty P; Shannon C; Silveira MJ
    JAMA Netw Open; 2021 Sep; 4(9):e2124152. PubMed ID: 34495339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
    Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
    Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Understanding Buprenorphine for Use in Chronic Pain: Expert Opinion.
    Webster L; Gudin J; Raffa RB; Kuchera J; Rauck R; Fudin J; Adler J; Mallick-Searle T
    Pain Med; 2020 Apr; 21(4):714-723. PubMed ID: 31917418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Phase I Placebo-Controlled Trial Comparing the Effects of Buprenorphine Buccal Film and Oral Oxycodone Hydrochloride Administration on Respiratory Drive.
    Webster LR; Hansen E; Cater J; Smith T
    Adv Ther; 2020 Nov; 37(11):4685-4696. PubMed ID: 32978722
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Buprenorphine - an attractive opioid with underutilized potential in treatment of chronic pain.
    Khanna IK; Pillarisetti S
    J Pain Res; 2015; 8():859-70. PubMed ID: 26672499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frontline Perspectives on Buprenorphine for the Management of Chronic Pain.
    Adler J; Mallick-Searle T; Garofoli M; Zimmerman A
    J Multidiscip Healthc; 2024; 17():1375-1383. PubMed ID: 38563040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Partial versus full agonists for opioid-mediated analgesia--focus on fentanyl and buprenorphine.
    Zuurmond WW; Meert TF; Noorduin H
    Acta Anaesthesiol Belg; 2002; 53(3):193-201. PubMed ID: 12461829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Switching from high doses of pure μ-opioid agonists to transdermal buprenorphine in patients with cancer: a feasibility study.
    Lundorff L; Sjøgren P; Hansen OB; Jonsson T; Nielsen PR; Christrup L
    J Opioid Manag; 2013; 9(4):255-62. PubMed ID: 24353018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Behavioral Effects of Opioid Full and Partial Agonists During Chronic Buprenorphine Treatment.
    Withey SL; Spealman RD; Bergman J; Paronis CA
    J Pharmacol Exp Ther; 2019 Nov; 371(2):544-554. PubMed ID: 31413139
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transdermal Buprenorphine for Acute Pain in the Clinical Setting: A Narrative Review.
    Pergolizzi JV; Magnusson P; LeQuang JA; Breve F; Mitchell K; Chopra M; Varrassi G
    J Pain Res; 2021; 14():871-879. PubMed ID: 33833565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Buprenorphine: considerations for pain management.
    Johnson RE; Fudala PJ; Payne R
    J Pain Symptom Manage; 2005 Mar; 29(3):297-326. PubMed ID: 15781180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Continuous Perioperative Sublingual Buprenorphine.
    Silva MJ; Rubinstein A
    J Pain Palliat Care Pharmacother; 2016 Dec; 30(4):289-293. PubMed ID: 27736284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Buprenorphine-Clinically useful but often misunderstood.
    Butler S
    Scand J Pain; 2013 Jul; 4(3):148-152. PubMed ID: 29913911
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.